|
Pfizer will now employ Novavax’s adjuvant, Matrix-M, into its vaccines across two disease areas.
|
 |
|
The partnership aims to deploy AI capabilities that automatically analyse X-ray and CT images to assist radiologists.
|
|
|
Aspect will acquire rights from Novo Nordisk to stem cell-derived islet cell and hypoimmune cell engineering technologies.
|
|
|
In December 2025, the UK Government announced a landmark pharmaceuticals agreement with the US that secures tariff-free access to the world’s largest medicines market and reshapes domestic pricing rules to accelerate patient access to innovative treatments.
|
|
|
Dr Karsten Eastman, CEO, Sethera Therapeutics, highlights the challenges around ‘true’ diversification in DNA libraries.
|
|
